AKT1 and osteosarcoma: On the contrary, FER1L4 expression is inhibited in osteosarcoma, and overexpression of FER1L4 can alleviate osteosarcoma cell apoptosis and epithelial-mesenchymal transition by inhibiting the PI3K/AKT pathway [49].